Immunological and stromal barriers against optimal #NK cell activity in #solidtumors
#Phenomics #tumor #molecularcancer
molecular-cancer.biomedcentral.com/articles/10.11…
Send in your #moldx #molpath advancements for consideration today! J Mol Diagnostics, the flagship journal of Association for Molecular Pathology, submission is free, we publish advancements in the diagnosis of #infectiousdisease #genetics , #solidtumors , #hematopathology , and #informatics .
editorialmanager.com/jmdi/default2.…
Tuning in to the 23rd Annual Needham & Company Healthcare Conference? Connect virtually with our CFO, Kathy Bergsteinsson, to learn more about our work targeting #oncogenicdriver mutations in #solidtumors .
Meet the Author Amin Nassar, MD by Journal for ImmunoTherapy of Cancer
Yale Cancer Center Yale New Haven Hosp
#Cancer #Cancer Treatment #ClinicalOutcomes #OncoDaily #Oncology #ParaneoplasticSyndromes #SolidTumors #ThoracicOncology #TreatmentInnovations #TumorImmunology
oncodaily.com/54852.html
JCWO supports a free of cost #MolecularDiagnostics program for the control and survival of patients affected by various types of cancers such as #Leukemia , #SolidTumors .
Learn more bit.ly/3q98PbF
#Programs #JCWO
Paper summary by Marco Donia
The Lancet Sandra P D'Angelo, MD
#Cancer #OncoDaily #Oncology #SolidTumors #Sarcoma #SynovialSarcoma #TCellTherapy #Cancer Research #clinicaltrials
oncodaily.com/52267.html
Come today to see our poster 1242 at ASGCT , 'Dissecting the Mechanisms of CAR-T Cell Dysfunction in a Mouse Model of Solid Tumors', presented by the super talented PhD student Paula Barbao. It's a bit hidden, but you can’t miss it! #asgct2023 #cart #solidtumors
Preclinical study showed that the depletion of regulatory T cells increases the anti-tumor effect of in situ vaccination in multiple solid tumors: doi.org/10.1016/j.phrs…
#Tcells #solidtumors #PharmacolRes #openaccess #Research #PharmaTwitter #MedTwitter
New Precision Cancer Therapy Targets Hard-to-Treat Tumors - sciencefeatured.com/2024/02/21/new… #breakthrough #targetedtherapy #precisionmedicine #cancertreatment #solidtumors #sciencefeatured #sciencenews
New technique improves T cell-based immunotherapies for #solidTumors Nature Biomedical Engineering medicalxpress.com/news/2024-05-t…
#SITC23 Society for Immunotherapy of Cancer │ Abstract 151 #Genetic heterogeneity between paired primary & metastatic #solidtumors & implications for #neoantigen -based personalized cancer #vaccines │ Oncology Research Information Exchange Network (ORIEN) Team Science Moffitt Cancer Center
Exciting #IO360nyc keynote by Dr. Dr Marcela Maus of MGH on #solidtumors & #CART . Loss of IFNyR signaling in solid tumors can drive resistance and CAR-T cytotoxicity suggesting a “crucial role of IFNyR in stabilizing and enhancing solid tumor CAR T cell interactions.” #CancerResearch
Did you know that 90% of diagnosed cancers form solid tumors? The Wyss' novel metabolic labeling technology can better target cancer cells buried deep in tumor masses. Learn more: bit.ly/3SS3Uet
#InternationalDayOfImmunology #SolidTumors #CancerResearch
#SITC2023 last day - large audience!
Really excited by all the tremendous advancement in the #cellbased #immunotherapies #engineering #precisionimmunotherapy #solidTumors !
It is the final day of the #EHA -The EBMT 6th European CAR T-cell Meeting #CART24 . Join us today for sessions on #multiplemyeloma , #solidtumors , & a keynote lecture by Fabio Ciceri. Today is your final chance to browse posters in person.
View the program: eha.fyi/CART2024_Progr…
Looking forward to presenting preclinical data on our lead program, IMM-1-104, AACR Annual Meeting 2024 in San Diego next Tuesday.
#RASMutations #UniversalRAS #MAPKPathway #SolidTumors #DrugDiscovery #CancerResearch #MetastaticCancer #AdvancedCancer
This Sunday is #WorldCancerDay . #Solidtumors are the most common form of cancer, but many lack safe and effective therapies. At SOTIO, we’re developing next-generation #cancer therapeutics to improve outcomes for patients with solid tumors.
#biotechnology
Our AMPLIFY-201 Phase 1 study on #CancerVaccine ELI-002 2P has been published in nature Medicine. Hear from our EVP/CMO, Dr. Christopher Haqq, on the preliminary data and what this could mean for patients with #SolidTumors . brnw.ch/21wGwqO
